EchoNous, a startup that markets a compact, AI-powered ultrasound device, raised $7 million. The funding was noted in a SEC filing and confirmed by a company spokesperson.
- Echonous’ flagship device is an AI-guided point-of-care ultrasound system, called Kosmos, that can image the heart and other regions of the body.
- The Redmond, Wash.-based company says the device provides diagnostic-quality images that rival those from bulkier, less portable and more expensive devices. Kosmos’ deep learning algorithms help operators collect images, label them, and automatically calculate key measurements like the heart’s ejection fraction.
- Kosmos was rated highly for overall image quality in a recent independent study evaluating five different hand-held ultrasound devices.
- Echonous announced a partnership in June with remote healthcare company 19Labs that links its virtual health platform to the Kosmos system. The aim is to provide better care to underserved communities and improve ultrasound education with Echonous’ tech to help teach users virtually in real time.
- The new funding comes from Kennedy Lewis, Echonous’ principal investor. Previous funding for the eight-year old startup includes $57 million raised in September 2022 as part of a Series D round and $60 million raised in September 2021.
